KYNTRA BIO, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
KYNTRA BIO, INC. (KYNB) had Lessee, Operating Lease, Liability, to be Paid, Year One of $17.55 million as of 2023-12-31, per its 10-K filed 2024-02-26.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2024-02-26
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $17.55M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $13.91M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $15.39M.
- 2021-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $15.52M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2023-12-31 | $17.55M 10-K · filed 2024-02-26 |
| 2022-12-31 | $13.91M 10-K · filed 2023-02-27 |
| 2021-12-31 | $15.39M 10-K/A · filed 2022-03-04 |
| 2021-09-30 | $15.52M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $15.52M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $1.60M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.14M 10-K · filed 2021-03-01 |
| 2020-09-30 | $714.00K 10-Q · filed 2020-11-05 |
| 2019-12-31 | $1.04M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |